Anti-Respiratory Syncytial Virus 抗体 [2F7] (ab43812)

ab43812 を使用した論文を発表された方は、こちらまでお知らせください。データシートに掲載させていただきます。

ab43812 は 5 報の論文で使用されています。

  • Liang B  et al. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate. J Virol 89:9499-510 (2015). PubMed: 26157122
  • Mackow N  et al. Attenuated Human Parainfluenza Virus Type 1 (HPIV1) Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus (RSV) as a Bivalent HPIV1/RSV Vaccine. J Virol 89:10319-32 (2015). PubMed: 26223633
  • Nguyen PQ  et al. Antiviral Cystine Knot a-Amylase Inhibitors from Alstonia scholaris. J Biol Chem 290:31138-50 (2015). PubMed: 26546678
  • Liang B  et al. Chimeric bovine/human parainfluenza virus type 3 expressing respiratory syncytial virus (RSV) F glycoprotein: effect of insert position on expression, replication, immunogenicity, stability, and protection against RSV infection. J Virol 88:4237-50 (2014). WB . PubMed: 24478424
  • Krzyzaniak MA  et al. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the f protein. PLoS Pathog 9:e1003309 (2013). PubMed: 23593008

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"